Sector dividends ICON Public Limited Company
Equities
ICLR
IE0005711209
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 187.94 USD | +1.17% |
|
+1.19% | -10.74% |
| Dec. 02 | Icon survey reveals increasing clinical trial startup delays | RE |
| Dec. 02 | Icon plc Announces Results of Its Latest Industry Survey | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 28.76x | 1.52x | 2.13x | 10.89x | 12.12x | 14.19B | ||
| 0.91% | 1.03% | 38.11x | 3.93x | 5.55x | 18.74x | 27.34x | 48.03B | ||
| -.--% | -.--% | 31.66x | 6.03x | 3.19x | 13.77x | 21.58x | 38.3B | ||
| -.--% | -.--% | 106.47x | 9.17x | 6.49x | 65.17x | 100.81x | 36.67B | ||
| 0.4% | 0.43% | 51.29x | 2.27x | 9.9x | 27.99x | 36.4x | 27.13B | ||
| -.--% | -.--% | 36.8x | 36.74x | 5.95x | 27.03x | 28.32x | 15.35B | ||
| -.--% | -.--% | -14.06x | 9.56x | 5482.71x | -13.3x | -13.09x | 15.17B | ||
| -.--% | -.--% | -51.36x | 33.47x | 11.07x | 28502.9x | -205.63x | 13.58B | ||
| -.--% | -.--% | -36.33x | 48.12x | 13.77x | -39.3x | -34.45x | 13.25B | ||
| -.--% | -.--% | -52.87x | 1375.83x | 15.07x | -123.59x | -89.45x | 12.74B | ||
| 1.08% | 1.18% | 23.17x | 2.03x | 1.93x | 8.78x | 13.45x | 12.2B | ||
| 0.44% | 0.4% | 24.5x | 2.72x | 5.07x | 13.72x | 17.12x | 10.21B | ||
| 0.5% | 0.5% | 49.51x | 4.55x | 8.04x | 22.68x | 24.73x | 9.9B | ||
| -.--% | -.--% | 43.89x | 2.57x | 2.75x | 11.4x | 13.87x | 9.06B | ||
| 0.71% | 0.87% | 29.47x | 3.41x | 3.62x | 14.93x | 23.46x | 6.88B | ||
| 1.04% | 1.01% | 30.69x | 1.9x | 5.7x | 22.45x | 24.54x | 5.67B | ||
| Average | 0.32% | 0.34% | 21.23x | 96.49x | 348.93x | 1,786.52x | 0.07x | 18.02B | |
| Weighted average by Cap. | 0.31% | 0.33% | 31.36x | 70.51x | 294.68x | 1,355.13x | 13.36x |
- Stock Market
- Equities
- ICLR Stock
- Sector ICON Public Limited Company
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















